Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea
· Delayed Price · Currency is KRW 106,700
0.00 (0.00%)
Apr 29, 2026, 10:10 AM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 9.04 trillion as of April 28, 2026. Its market cap has increased by 155.25% in one year.
Market Cap
9.04T
Enterprise Value
9.04T
Revenue
5.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
106,700.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 9.04T, an increase of 250.68%. That is a compound annual growth rate of 15.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 8,357.72B |
| SK Biopharmaceuticals | 8,034.94B |
| LigaChem Biosciences | 7,415.45B |
| Peptron | 6,307.34B |
| Voronoi | 5,507.62B |
| Samsung Epis Holdings | 14.08T |
| OliX Pharmaceuticals | 3,989.06B |
| ALTEOGEN | 20.15T |